BackOpiant Pharmaceuticals Overview

Opiant Pharmaceuticals Receivables

Track Opiant Pharmaceuticals's receivables ($41K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$41113.00
↓ 99.73% YoYΔ $-15.38M vs prior year quarter

Peer trimmed avg / median

Loading

Opiant Pharmaceuticals Receivables History

Loading

Opiant Pharmaceuticals vs. peers: Receivables Comparison

Loading

Opiant Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Opiant Pharmaceuticals (OPNT) FAQ

Opiant Pharmaceuticals (OPNT) currently reports a receivables of $41K as of September 2022. That compares with $15M in the prior-year period — down 99.7% year over year. Use the charts on this page to explore Opiant Pharmaceuticals's receivables history and peer comparisons.

Opiant Pharmaceuticals's receivables decreased from $15M to $41K — a 99.7% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opiant Pharmaceuticals reported $41K in receivables as of September 2022. That compares with $15M in the prior-year period — down 99.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $41K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Opiant Pharmaceuticals, and consider following OPNT for alerts when major investors trade the stock.

Opiant Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $41K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPNT with unrelated industries.